Utah Medical Products (UTMD) Cash from Investing Activities (2010 - 2026)
Utah Medical Products (UTMD) posted quarterly Cash from Investing Activities of -$130000.0 for Q1 2026, up 29.35% year-over-year from -$100504.2 in Q1 2025, and down 19.27% quarter-over-quarter from -$109000.0 in Q4 2025.
Utah Medical Products (UTMD) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Utah Medical Products' Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$130000.0 for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 29.35% year-over-year to -$130000.0; the TTM figure through Mar 2026 stood at -$317000.0 (up 20.15% YoY), while the FY2025 annual figure was -$371000.0, down 78.37% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$130000.0, down from -$109000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $5000.0 in Q1 2024, with the low at -$321000.0 in Q3 2022.
- The 5-year median for Cash from Investing Activities is -$109000.0 (2025), against an average of -$127411.8.
- The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities soared 111.63% in 2024, then tumbled 3780.0% in 2025.
- Utah Medical Products' Cash from Investing Activities stood at -$38000.0 in 2022, then plunged by 136.84% to -$90000.0 in 2023, then jumped by 90.0% to -$9000.0 in 2024, then slumped by 1111.11% to -$109000.0 in 2025, then declined by 19.27% to -$130000.0 in 2026.
- Business Quant data shows UTMD's Cash from Investing Activities at -$130000.0 in Q1 2026, -$109000.0 in Q4 2025, and -$27000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Utah Medical Products | 227.50 Mn | 139.97 Mn | 4.76 Mn | -134,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -134,000.00 |
| Jun 30, 2026 | -134,000.00 |
| Mar 31, 2026 | -130,000.00 |
| Mar 31, 2026 | -130,000.00 |
| Dec 31, 2025 | -109,000.00 |
| Dec 31, 2025 | -109,000.00 |
| Sep 30, 2025 | -27,000.00 |
| Sep 30, 2025 | -27,000.00 |
| Jun 30, 2025 | -51,000.00 |
| Jun 30, 2025 | -51,000.00 |
| Mar 31, 2025 | -184,000.00 |
| Mar 31, 2025 | -184,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Sep 30, 2024 | -89,000.00 |
| Sep 30, 2024 | -89,000.00 |
| Jun 30, 2024 | -115,000.00 |
| Jun 30, 2024 | -115,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |